跳至主要内容
临床试验/NCT02910362
NCT02910362已完成不适用

Intra-surgical Evaluation of CATS Tonometer Prism and AMO Versus Alcon Phacoemulsification Machines

Intuor Technologies, Inc.2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
2
主要终点
Number of Eyes With Stable IOP

研究概览

简要总结

This study will measure the dynamic real-time intraocular pressure (IOP) in the anterior chamber during standard phacoemulsification surgery.

What is known:

  • Fluidics control is determined to be one of the primary drivers of physician decision making in choosing phacoemulsification equipment.
  • Active pressure system fluidic control has a perceived and possibly real (based upon recent literature) improvement in intra-cameral IOP stability and reduced pressure fluctuations.
  • Improved fluidics can allow for reduced dynamic IOP fluctuations, in-the-bag positioned phaco tip, and intra-cameral fluid flow all of which will likely improve corneal health post-operatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Age 18 or greater
  • Bilateral cataracts for which phacoemulsification extraction and posterior IOL implantation has been planned for both eyes
  • Subjects able to give informed consent
  • Nuclear Sclerotic cataract graded 2+ or 3+
  • Naturally dilated pupil size (in dim light) > 4.0 mm (with no dilation medications) for both eyes
  • Preoperative corneal astigmatism of 2.5 D or less
  • Ages between 55 and 80
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures

排除标准

  • • Uncontrolled systemic disease that in the opinion of the Investigator would put the subject's heath at risk
  • Intraoperative complications
  • Subjects with only one functional eye
  • Those with one eye having poor or eccentric fixation
  • Mild or severe cataracts, predominantly posterior subcapsular cataracts
  • High corneal astigmatism (i.e. those eyes displaying an oval contact image)
  • Those with corneal scarring or who have had corneal surgery including corneal laser surgery
  • Microphthalmos
  • Buphthalmos
  • Severe Dry eyes
  • Blepharospasm
  • Nystagmus
  • Keratoconus
  • Any other corneal or conjunctival pathology or infection.
  • Central corneal thickness greater than 0,600 mm or less than 0,500 mm (2 standard deviations about the human mean)
  • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus, immunocompromised, etc.)
  • Uncontrolled systemic or ocular disease
  • History of ocular trauma or prior ocular surgery
  • Fuchs Dystrophy
  • Subjects who may be expected to require retinal laser treatment or other surgical intervention, including LRI's
  • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome)
  • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils, or pupils that do not dilate at least 4.0 mm under mesopic/scotopic conditions)
  • Contact lens usage within 6 months for PMMA contacts lenses, 1 month for gas permeable lenses or 1 week for extended-wear and daily-wear soft contact lens

研究组 & 干预措施

Alcon phacoemulsification equipment

Experimental

cataract surgery performed with the Alcon phacoemulsification equipment

干预措施: Alcon phacoemulsification equipment (Device)

AMO phacoemulsification equipment

Active Comparator

cataract surgery with the AMO phacoemulsification equipment

干预措施: AMO phacoemulsification equipment (Device)

结局指标

主要结局

Number of Eyes With Stable IOP

时间窗: intraoperative

Determine comparative IOP stability between Abbott and Alcon phacoemulsification equipment.

次要结局

未报告次要终点

研究者

发起方
Intuor Technologies, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验